Pharmaphobia : how the conflict of interest myth undermines American medical innovation
著者
書誌事項
Pharmaphobia : how the conflict of interest myth undermines American medical innovation
Rowman & Littlefield, c2015
- : cloth
大学図書館所蔵 全2件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
For millennia, human survival depended on our innate abilities to fight pathogens and repair injuries. Only recently has medical science prolonged longevity and improved quality of life. Physicians and academic researchers contribute to such progress, but the principal contributor is private industry that produces the tools - drugs and medical devices - enabling doctors to prevent and cure disease. Heavy regulation and biology's complexity and unpredictability make medical innovation extremely difficult and expensive.
Pharmaphobia describes how an ideological crusade, stretching over the last quarter century, has used distortion and flawed logic to make medical innovation even harder in a misguided pursuit of theoretical professional purity. Bureaucrats, reporters, politicians, and predatory lawyers have built careers attacking the medical products industry, belittling its critical contributions to medical innovation and accusing it of non-existent malfeasance: overselling product value, flaunting safety and corrupting physicians and academics who partner with it. The mania has imposed "conflict-of-interest" regulations limiting or banning valuable interactions between industry and physicians and researchers and diverting scarce resources from innovation to compliance. The victims are patients suffering from cancer, dementia, and other serious diseases for which new treatments are delayed, reduced, or eliminated as a result of these pointless regulations. With breathtaking detail, Thomas Stossel shows how this attack on doctors who work with industry limits medical innovation and inhibits the process of bringing new products into medical care.
目次
Introduction
Part I: Some Benefits and the Mechanics of Medical Innovation
Chapter 1: The Stakes
Chapter 2: A Practitioner's History of Medical Innovation
Part II: Why We Have a Medical Innovation Crisis
Chapter 3: Enter the Conflict-of-Interest Mania
Chapter 4: The Mania Mongers
Part III: Why They Are Wrong
Chapter 5: Abusing Evidence
Chapter 6: Bad Policy Process
Chapter 7: Flawed and Damaging Policies
Chapter 8: Misunderstanding Innovation
Chapter 9: Economic Illiteracy
Chapter 10: Misplaced Criticism of Incremental Innovation
Chapter 11: Rushing to Judgment with Product Safety Alarms
Chapter 12: Demonizing Marketing is False Advertising
Chapter 13: The "Gift" Smoke Screen
Chapter 14: The Lawyers' Ball
Part IV: The Damage They Do and How to Stop It
Chapter 15: The Price We Pay
Chapter 16: What Is To Be Done?
「Nielsen BookData」 より